| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,074 |
26,531 |
$2.72M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,118 |
9,693 |
$1.30M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,590 |
14,859 |
$1.02M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,084 |
1,224 |
$407K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,437 |
1,114 |
$399K |
| 80053 |
Comprehensive metabolic panel |
44,426 |
38,264 |
$310K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,413 |
10,605 |
$306K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
47,696 |
40,256 |
$244K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,141 |
634 |
$231K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,475 |
6,818 |
$207K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,765 |
10,068 |
$191K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,737 |
7,163 |
$171K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,499 |
5,025 |
$170K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,535 |
5,023 |
$170K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
786 |
612 |
$166K |
| 87428 |
|
4,819 |
4,218 |
$148K |
| 36415 |
Collection of venous blood by venipuncture |
69,391 |
57,051 |
$142K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,575 |
4,154 |
$139K |
| 71045 |
Radiologic examination, chest; single view |
8,493 |
7,374 |
$136K |
| 80061 |
Lipid panel |
11,882 |
10,652 |
$128K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,149 |
2,695 |
$127K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
265 |
243 |
$110K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,357 |
4,203 |
$89K |
| 70450 |
Computed tomography, head or brain; without contrast material |
864 |
763 |
$71K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
626 |
534 |
$65K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
297 |
205 |
$61K |
| 84484 |
|
8,662 |
7,392 |
$59K |
| 84703 |
|
8,711 |
7,566 |
$50K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,208 |
3,742 |
$49K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,401 |
1,115 |
$46K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,774 |
5,110 |
$44K |
| 81001 |
|
19,593 |
17,007 |
$41K |
| 80050 |
General health panel |
1,077 |
996 |
$41K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,136 |
942 |
$39K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
84 |
78 |
$37K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
856 |
754 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,678 |
1,279 |
$34K |
| 83735 |
|
7,772 |
6,841 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
1,007 |
921 |
$24K |
| 97597 |
|
1,673 |
782 |
$21K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
103 |
78 |
$21K |
| 81514 |
|
156 |
128 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
931 |
824 |
$18K |
| 83880 |
|
867 |
777 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
444 |
331 |
$15K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
243 |
203 |
$14K |
| 86803 |
|
1,074 |
968 |
$13K |
| 83690 |
|
2,828 |
2,512 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
940 |
807 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
285 |
267 |
$11K |
| 84403 |
|
482 |
435 |
$10K |
| 82553 |
|
1,775 |
1,483 |
$10K |
| 87486 |
|
253 |
243 |
$10K |
| 87581 |
|
253 |
243 |
$10K |
| 86592 |
|
2,504 |
2,275 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
223 |
199 |
$9K |
| 87340 |
|
942 |
848 |
$8K |
| 82550 |
|
2,030 |
1,700 |
$7K |
| 0001A |
|
325 |
213 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
911 |
831 |
$6K |
| 83615 |
|
1,783 |
1,503 |
$6K |
| 0002A |
|
318 |
171 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
917 |
806 |
$6K |
| G0378 |
Hospital observation service, per hour |
35 |
16 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
404 |
229 |
$5K |
| 84439 |
|
656 |
566 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,921 |
1,621 |
$4K |
| 80076 |
|
605 |
551 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
127 |
120 |
$3K |
| 87081 |
|
604 |
515 |
$3K |
| 83605 |
|
525 |
442 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
75 |
70 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
184 |
104 |
$2K |
| 81025 |
|
438 |
367 |
$2K |
| 86696 |
|
72 |
69 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
443 |
384 |
$2K |
| 84153 |
|
119 |
102 |
$2K |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
1,216 |
1,073 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
53 |
35 |
$1K |
| 81003 |
|
1,005 |
879 |
$1K |
| 86695 |
|
72 |
69 |
$1K |
| 87481 |
|
41 |
25 |
$1K |
| 86701 |
|
127 |
118 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,772 |
1,498 |
$1K |
| 87210 |
|
258 |
233 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
443 |
389 |
$988.40 |
| 80081 |
|
17 |
15 |
$973.18 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
17 |
17 |
$799.20 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,625 |
950 |
$779.59 |
| 82077 |
|
85 |
76 |
$725.20 |
| 80143 |
|
42 |
39 |
$531.24 |
| 80179 |
|
41 |
39 |
$517.26 |
| 87522 |
Neg quan hep c or qual rna |
15 |
13 |
$471.24 |
| 87150 |
|
15 |
13 |
$421.08 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$416.04 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
96 |
73 |
$393.09 |
| 86140 |
|
113 |
99 |
$336.70 |
| 87077 |
|
39 |
36 |
$313.13 |
| 83655 |
|
26 |
25 |
$309.10 |
| 82728 |
|
25 |
24 |
$299.86 |
| 85027 |
|
45 |
45 |
$291.15 |
| 87040 |
|
35 |
29 |
$268.32 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
469 |
401 |
$238.55 |
| 80320 |
|
370 |
275 |
$215.36 |
| 83550 |
|
25 |
24 |
$192.28 |
| J2704 |
Injection, propofol, 10 mg |
2,494 |
1,831 |
$187.46 |
| 85379 |
|
13 |
13 |
$111.98 |
| 86708 |
|
14 |
12 |
$111.51 |
| 17250 |
|
14 |
12 |
$107.36 |
| 88342 |
|
94 |
74 |
$99.68 |
| 85610 |
|
33 |
29 |
$85.80 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
24 |
14 |
$70.49 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
200 |
177 |
$68.97 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
36 |
24 |
$65.32 |
| 82962 |
|
124 |
110 |
$57.08 |
| 82043 |
|
14 |
13 |
$52.02 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
77 |
57 |
$37.19 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
71 |
53 |
$31.13 |
| 85730 |
|
18 |
15 |
$30.05 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
21 |
14 |
$14.82 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
13 |
13 |
$11.71 |
| C9113 |
Injection, pantoprazole sodium, per vial |
16 |
13 |
$9.74 |
| 99156 |
|
2,627 |
1,877 |
$7.87 |
| 91300 |
|
426 |
369 |
$4.19 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
108 |
93 |
$2.46 |
| 99157 |
|
1,505 |
1,002 |
$0.00 |
| 99152 |
|
251 |
180 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
525 |
437 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
154 |
114 |
$0.00 |
| 00000 |
|
27 |
25 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
20 |
14 |
$0.00 |